What is the appropriate dose of diphenhydramine (antihistamine) for a 12-year-old child weighing 36kg experiencing vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diphenhydramine Dosing for a 12-Year-Old with Vomiting

Diphenhydramine is NOT recommended as a first-line antiemetic for vomiting in a 12-year-old child, but if used, the appropriate dose would be 12.5-25 mg orally every 4-6 hours as needed. 1

Why Diphenhydramine Should Not Be First-Line for Vomiting

  • Diphenhydramine is primarily indicated for dystonic reactions from other antiemetics (like metoclopramide or prochlorperazine), not as a primary antiemetic agent. 1
  • The evidence supports ondansetron as the preferred antiemetic for pediatric vomiting, with a dose of 0.2 mg/kg oral (maximum 4 mg) for children unable to take fluids due to persistent vomiting. 2, 3
  • Diphenhydramine has significant anticholinergic side effects including oversedation, confusion, and impaired psychomotor performance that make it less favorable than alternatives. 1, 4, 5

If Diphenhydramine Must Be Used

For a 36 kg child, the appropriate dose is 12.5-25 mg orally every 4-6 hours during the vomiting episode. 1

Dosing Specifics:

  • The FDA-approved dosing for children 6 to under 12 years is 10 mL (25 mg) every 4-6 hours, not to exceed 6 doses in 24 hours. 6
  • Since this child is 12 years old, they fall into the "adults and children over 12 years" category, which allows 10-20 mL (25-50 mg) every 4-6 hours. 6
  • Start with the lower dose of 12.5-25 mg given the child's weight and age at the transition point. 1, 6

Critical Safety Considerations

  • Monitor for anticholinergic effects: confusion, excessive sedation, dry mouth, blurred vision, urinary retention, and tachycardia. 4, 7
  • Avoid rapid administration if given intravenously, as this increases risk of seizures and cardiovascular toxicity. 4
  • The toxic dose threshold is 7.5 mg/kg (270 mg for this 36 kg child), which would require emergency department referral. 8
  • Do not use for sleep or as routine antiemetic - newer alternatives are safer and more effective. 4, 5

Preferred Alternative Approach

For gastroenteritis-related vomiting, ondansetron 0.2 mg/kg oral (7.2 mg for this child, round to 8 mg) is superior to diphenhydramine. 2, 3

  • Ondansetron reduces vomiting, facilitates oral rehydration therapy, and has fewer adverse effects than older antiemetics. 3
  • For low emetogenic risk situations, other options include metoclopramide or prochlorperazine (though these carry dystonic reaction risk). 1

When to Escalate Care

  • Bilious or bloody vomiting, altered mental status, severe dehydration, or symptoms persisting beyond 4 hours warrant emergency department evaluation regardless of medication choice. 2, 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of a child with vomiting.

Indian journal of pediatrics, 2013

Guideline

Diphenhydramine Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diphenhydramine: Time to Move on?

The journal of allergy and clinical immunology. In practice, 2022

Guideline

Diphenhydramine Use in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The vomiting child--what to do and when to consult.

Australian family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.